Nanotechnology Now - Press Release: GBI Research New Report

Home > Press > GBI Research New Report - Nanotechnology in Drug Delivery

Abstract:
The Nano-Enabled Market Represents Significant Opportunities and High Level of Unmet Needs

GBI Research New Report - Nanotechnology in Drug Delivery

Posted on November 8th, 2010

The nano-enabled drug delivery market has plenty of opportunities and a high level of unmet need. Opportunities for creating a new drug delivery company are tremendous. Many small companies have launched the technology to develop novel methods for exploiting nanotechnologies in drug delivery. In the past, companies have been dedicated to the nano-enabled drug delivery that has been popping up all over the world.

The creation of new companies will not only increase the investment and market growth, but also increase the competition in the market place. In addition, the emergence of new companies will provide licensing and merger and acquisition (M&A) opportunities for larger pharmaceutical markets.

The market is also characterized by high levels of unmet need. This is primarily because
development in this area is in its initial stages and has a significant number of unaddressed issues such as nanotoxicity, biological behavior and distribution pattern of nanoparticles. These unmet needs represent a significant opportunity for companies to explore.

In summary, high growth in the nano-enabled drug delivery markets will provide significant opportunities for companies.

The increasing investment in the nano-enabled drug delivery market has significantly driven the market. Funding for nanotechnology programs increased during the administration of George Bush.

The nanotechnology funding is expected to increase significantly in the future. Among all the major geographies, the European government is investing more in nanotechnology R&D. This suggests that there will be increased governmental support for anotechnology R&D. In addition, increase in early stage venture capital will also affect the market positively.

GBI Research, the leading business intelligence provider, has released its latest report,
"Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential" that provides key data, information and analysis of the major trends and issues in Nanotechnology in Drug Delivery market. The report provides a comprehensive insight into the role of Nanotechnology in Drug Delivery. The report also provides a detailed analysis of market characterization of nanotechnology in drug delivery market in terms of its market size, segmentation by key geography types and the major market drivers and barriers. The report also talks about the technological trends over the years in use of nanotechnology in drug delivery.

For further details, please click or add the below link to your browser:
www.gbiresearch.com/Report.aspx?ID=Nanotechnology-in-Drug-Delivery-Technological-Improvements-and-Novel-Approaches-to-Fulfill-High-Potential&ReportType=Industry_Report&coreindustry=ALL&Title=Pharmaceuticals_and_Healthcare

####

About GBI Research
GBI Research is a market-leading provider of business intelligence reports. GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders’ insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

For more information, please click here

Contacts:

North America:+1 646 395 5477
Europe:+44 207 753 4299
+44 1204 543 533
Asia Pacific:+91 40 6616 6782

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: